http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212993-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c14b7a5c959643f4d911b0597706fdd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f72c012dd58d936db8f5f42c39ebd54a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb0f3b9b233b0cdd546c13570f5914f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a16aacb7cb1b371dbe84d231a06aa552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f32e3c50b9c03233fbd6f811aa88b2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246fec6db4944ea64e8094341e128d0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82295e92d256277efa8c236c9ec19a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443787b39e9756e01cd37ee6f21d74f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2cd15f324506003677d71f8ee846be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31eb137fa65eeb478f77401bd3e14da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7239e0070d1e0f68f9f854cb4c6431d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f37c80cfa722073fec39122e6d13c4d
publicationDate 2011-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011212993-A1
titleOfInvention Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
abstract The invention relates to an ophthalmic medicament for treating glaucoma which comprises a clathrate compound prepared by dissolving cilostazol or a salt thereof in a cyclodextrin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206129-B2
priorityDate 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006154963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1396266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002032171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004209843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006034847-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226567204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246087738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455499262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129170378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128494910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID140296841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127645893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167

Total number of triples: 56.